Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
about
Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece.Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter studyIntrapulmonary pharmacokinetics of linezolidPharmacodynamics of moxifloxacin against Streptococcus pyogenes in an in vitro kinetic model.Quinupristin-dalfopristin: an overview.Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy.Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Genetic elements responsible for erythromycin resistance in streptococci.Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, ChinaResistance to macrolides and related antibiotics in Streptococcus pneumoniaeImmunoasssay chromatographic antigen test for rapid diagnosis of Group A beta hemolytic Streptococcus pharyngitis in children: A cross/ sectional studyNew genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae.Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration.Erythromycin resistance caused by erm(A) subclass erm(TR) in a Danish invasive pneumococcal isolate: are erm(A) pneumococcal isolates overlooked?
P2860
Q33971827-38972A47-FE93-4830-84B4-956B9EDD1F48Q33981283-B7F788E3-E935-4C61-B8D0-173D5E50F28DQ33981528-FA9A000C-CD8D-46AD-B210-5F1E3428B87AQ33982834-F8526A34-35CB-4E1C-BAAF-62AB281B6839Q34106719-31B304CB-2E81-4AB3-AB0E-45078785EA16Q34108406-FFFC68E7-E822-450B-86C1-31CAC7C357D3Q34113774-07C348AA-CFAC-4F6C-AF82-37737E345044Q34749258-146D0FA4-0A9C-47B3-8035-AC58D7F7D269Q35103743-5BE51ED5-91B6-4A0B-A901-6AFC29B629E7Q36083208-CAA4A881-C2B4-4C67-AAD9-E14F28FEDE76Q37322929-1FED5D5F-862A-4FB9-BD8A-648D6633B2F3Q37568392-CEFAA8E9-478D-4FED-9E73-3638A770C3C1Q39652725-6EE627AF-08B1-4536-9F90-FE3AAEFB98FDQ41130836-89648A45-CFEB-48E4-B353-C2BD5BF60271Q41855007-DF449A71-B695-4810-AFBB-4BB1CCD9BE7FQ46908564-D4EF42C7-F926-488B-9836-382BC6D5F479Q50547829-55DE0197-F82A-4971-8DA7-30FB72481E2F
P2860
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Comparative in vitro activitie ...... e and -resistant streptococci.
@ast
Comparative in vitro activitie ...... e and -resistant streptococci.
@en
type
label
Comparative in vitro activitie ...... e and -resistant streptococci.
@ast
Comparative in vitro activitie ...... e and -resistant streptococci.
@en
prefLabel
Comparative in vitro activitie ...... e and -resistant streptococci.
@ast
Comparative in vitro activitie ...... e and -resistant streptococci.
@en
P2093
P2860
P1476
Comparative in vitro activitie ...... e and -resistant streptococci.
@en
P2093
E Culebras
J J Picazo
P2860
P304
P356
10.1128/AAC.44.7.1838-1841.2000
P407
P577
2000-07-01T00:00:00Z